Averin Capital Acquisition Corp. (ACAA)
| Market Cap | 317.33M |
| Revenue (ttm) | n/a |
| Net Income | -440,298 |
| EPS | -0.07 |
| Shares Out | 31.45M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 139,384 |
| Open | 10.03 |
| Previous Close | 10.04 |
| Day's Range | 10.03 - 10.09 |
| 52-Week Range | 9.98 - 10.09 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About ACAA
Averin Capital Acquisition Corp. focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Averin Cap Acquisition Corp. was incorporated in 2025 and is headquartered in New York, New York.
News
Averin Capital Acquisition Corp. Announces Closing of Partial Exercise of IPO Over-Allotment Option
New York, NY, March 05, 2026 (GLOBE NEWSWIRE) -- Averin Capital Acquisition Corp. (the “Company”) (NASDAQ: ACAAU), announced today that the underwriter of its previously announced initial public offer...
U.S. IPO Weekly Recap: IPO Market Stays Fairly Quiet During The Short Holiday Week
One small issuer and four blank check companies went public this past week as the IPO market continued to weather the recent volatility. No deals are currently on the calendar for the week ahead, alth...
Averin Capital Acquisition Corp. Completes $250,000,000 Initial Public Offering
New York, NY, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Averin Capital Acquisition Corp. (the “Company”) announced today the closing of its initial public offering of 25,000,000 units. The offering was priced...
Averin Capital Acquisition Corp. Announces the Pricing of $250,000,000 Initial Public Offering
New York, NY, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Averin Capital Acquisition Corp. (the “Company”) announced today the pricing of its initial public offering of 25,000,000 units at a price of $10.00 per...
Averin Capital Acquisition IPO Registration Document (S-1)
Averin Capital Acquisition has filed to go public with an IPO on the NASDAQ
SPAC Averin Capital Acquisition files for a $250 million IPO, targeting health and life sciences sectors
Averin Capital Acquisition, a blank check company targeting health and life sciences, filed on Friday with the SEC to raise up to $250 million in an initial public offering.